FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35893911000001106: Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110909401000001113 Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110909501000001112 Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspensioninjection.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Is a Galactose + Palmitic acid true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Is a Product containing galactose and palmitic acid false Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has active ingredient Galactose false Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has active ingredient Palmitic acid false Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has specific active ingredient Palmitic acid true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Has specific active ingredient Galactose true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials 1 vial Has VMP True Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Inferred relationship Existential restriction modifier
Levovist powder and solvent for suspension for injection 2.5g vials (Schering Health Care Ltd) Is a True Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start